Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.

被引：0
|
作者：
Grizzi, Giulia
Petrelli, Fausto
Ghidini, Michele
Ghidini, Antonio
Ratti, Margherita
Panni, Stefano
Cabiddu, Mary
Ghilardi, Mara
Borgonovo, Karen
Parati, Maria Chiara
Barni, Sandro
Tomasello, Gianluca
Passalacqua, Rodolfo
Berruti, Alfredo
Brighenti, Matteo
机构：
[1] ASST Cremona, Oncol Dept, Oncol Unit, Cremona, Italy
[2] ASST Bergamo Ovest, Treviglio, Italy
[3] ASST Cremona, Oncol Unit, Cremona, Italy
[4] Osped Cremona, ASST Cremona, Cremona, Italy
[5] Univ Brescia, Spedali Civili Hosp, Med Oncol, Brescia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14130
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs).
    Vitale, Nuzzo Pier
    Pond, Gregory Russell
    Abou Alaiwi, Sarah
    Nassar, Amin
    Flippot, Ronan
    Choueiri, Toni K.
    Harshman, Lauren Christine
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Treatment-related adverse events of combination immune checkpoint inhibitors: Systematic review and meta-analysis.
    Park, Robin
    da Silva, Laercio Lopes
    Riano, Ivy
    Cristancho, Cagney
    Saeed, Anwaar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Preexisting autoantibodies as predictor of immune-related adverse events for advanced solid tumors treated with immune checkpoint inhibitors
    Daban, Arthur
    Gonnin, Cecile
    Vano, Yann-Alexandre
    Phan, Letuan
    Lillo-Lelouet, Agnes
    Le Beller, Christine
    Pouchot, Jacques
    Fabre, Elizabeth
    Weiss, Laurence
    Tartour, Eric
    Oudard, Stephane
    Durey, Marie-Agnes Dragon
    Simonaggio, Audrey
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Patterns of immune-related adverse events (irAEs) in adolescent and young adult (AYA) patients with melanoma receiving immune checkpoint inhibitors (ICIs)
    He, Jiasen
    John, Ida
    Afridi, Faraz
    Sun, Mianen
    Wang, Yinghong
    Roth, Michael
    McQuade, Jennifer Leigh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis
    Malani, Rachna
    Haggiagi, Aya
    Holder, Jenessa
    Shames, Yelena
    Briggs, Samuel
    Callahan, Margaret
    Santomasso, Bianca
    NEUROLOGY, 2018, 90
  • [26] Real world outcomes of immune-related adverse events (irAEs) among patients receiving immune checkpoint inhibitors (ICIs) in hospital settings
    George, S.
    Zheng, Y.
    Kim, R.
    Yu, T.
    Dreyfus, J.
    Gayle, J. A.
    Wassel, C.
    Phatak, H.
    ANNALS OF ONCOLOGY, 2019, 30 : 522 - 522
  • [27] Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
    Teng, Yi-Shan
    Yu, Sebastian
    CURRENT ONCOLOGY, 2023, 30 (07) : 6805 - 6819
  • [28] Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
    Muntyanu, Anastasiya
    Netchiporouk, Elena
    Gerstein, William
    Gniadecki, Robert
    Litvinov, Ivan V.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (01) : 59 - 76
  • [29] Eosinophil count and immune-related adverse events (irAEs) as predictive biomarkers of survival in patients with NSCLC treated with ICIs
    Giommoni, Elisa
    Pillozzi, Serena
    Ottanelli, Carlotta
    Cosso, Federica
    Caliman, Enrico
    Mazzoni, Francesca
    Fancelli, Sara
    Lavacchi, Daniele
    Brugia, Marco
    Pellegrini, Elisa
    Vannini, Agnese
    Napolitano, Brunella
    Sanza, Roberta Fuccio
    Shabani, Sonia
    Zepponi, Francesca
    Pasqui, Adriano
    Zenoni, Andrea
    Antonuzzo, Lorenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Autoimmune panels as predictors of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ALERT)
    Genta, S.
    Yee, N.
    Keshavarzi, S.
    Heirali, A.
    Hansen, A. R.
    Siu, L. L.
    Saibil, S.
    Stayner, L-A.
    Yanekina, M.
    Pimentel Muniz, T.
    Vilbert, M.
    Bedard, P.
    Abdul Razak, A. R.
    Coburn, B.
    Chruscinski, A.
    Spreafico, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S844 - S845
12345